Sio Capital Management, LLC Hedge Fund

Location: New York, NY

CIK: 0001482416 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $604M (100.0% shares, 0.0% debt)

Holdings (59)

New Positions (17)

ALLO ALLOGENE THERAPEUTICS INC 4.6%
Value $27.71M Shares 13,323,431 Share Price $2.08 Est. Cost/Share — Unrealized @ Report Date —
GMED GLOBUS MED INC 3.9%
Value $23.85M Shares 301,816 Share Price $79.01 Est. Cost/Share — Unrealized @ Report Date —
SLS SELLAS LIFE SCIENCES GROUP I 3.0%
Value $18.17M Shares 1,230,700 Share Price $14.76 Est. Cost/Share — Unrealized @ Report Date —
IDYA IDEAYA BIOSCIENCES INC 3.0%
Value $17.9M Shares 480,383 Share Price $37.27 Est. Cost/Share — Unrealized @ Report Date —
CI THE CIGNA GROUP 2.6%
Value $15.92M Shares 57,750 Share Price $275.68 Est. Cost/Share — Unrealized @ Report Date —
VTRS VIATRIS INC 2.5%
Value $15.15M Shares 954,299 Share Price $15.88 Est. Cost/Share — Unrealized @ Report Date —
REGN REGENERON PHARMACEUTICALS 1.9%
Value $11.22M Shares 18,000 Share Price $623.54 Est. Cost/Share — Unrealized @ Report Date —
BMY BRISTOL-MYERS SQUIBB CO 1.8%
Value $11.15M Shares 193,500 Share Price $57.62 Est. Cost/Share — Unrealized @ Report Date —
MDT MEDTRONIC PLC 1.8%
Value $11.15M Shares 142,500 Share Price $78.23 Est. Cost/Share — Unrealized @ Report Date —
HELP CYBIN INC 1.4%
Value $8.593M Shares 1,300,000 Share Price $6.61 Est. Cost/Share — Unrealized @ Report Date —
TNGX TANGO THERAPEUTICS INC 1.1%
Value $6.518M Shares 208,500 Share Price $31.26 Est. Cost/Share — Unrealized @ Report Date —
AVAH AVEANNA HEALTHCARE HLDGS INC 0.5%
Value $3.163M Shares 369,036 Share Price $8.57 Est. Cost/Share — Unrealized @ Report Date —
HIMS HIMS & HERS HEALTH INC 0.4%
Value $2.6M Shares 75,000 Share Price $34.67 Est. Cost/Share — Unrealized @ Report Date —
AORT ARTIVION INC 0.2%
Value $1.089M Shares 48,481 Share Price $22.47 Est. Cost/Share — Unrealized @ Report Date —
NMTC NEUROONE MED TECHNOLOGIES CO 0.0%
Value $252K Shares 82,767 Share Price $3.04 Est. Cost/Share — Unrealized @ Report Date —
ENVB ENVERIC BIOSCIENCES INC 0.0%
Value $248K Shares 180,000 Share Price $1.38 Est. Cost/Share — Unrealized @ Report Date —
QTI QT IMAGING HLDGS INC 0.0%
Value $62,011 Shares 15,236 Share Price $4.07 Est. Cost/Share — Unrealized @ Report Date —

Increased Positions (9)

Exited Positions (34)

CORT CORCEPT THERAPEUTICS INC 4.5%
Value $27.2M Shares 674,759 Share Price $40.31 Est. Cost/Share — Unrealized @ Report Date —
LIVN LIVANOVA PLC 4.4%
Value $26.8M Shares 421,615 Share Price $63.56 Est. Cost/Share — Unrealized @ Report Date —
EMBC EMBECTA CORP 2.7%
Value $16.33M Shares 1,847,850 Share Price $8.84 Est. Cost/Share — Unrealized @ Report Date —
ABVX ABIVAX SA 2.5%
Value $15.12M Shares 135,800 Share Price $111.35 Est. Cost/Share — Unrealized @ Report Date —
HAE HAEMONETICS CORP MASS 2.1%
Value $12.44M Shares 220,672 Share Price $56.36 Est. Cost/Share — Unrealized @ Report Date —
TFX TELEFLEX INCORPORATED 1.9%
Value $11.34M Shares 94,800 Share Price $119.61 Est. Cost/Share — Unrealized @ Report Date —
BMRN BIOMARIN PHARMACEUTICAL INC 1.8%
Value $10.97M Shares 194,226 Share Price $56.49 Est. Cost/Share — Unrealized @ Report Date —
GPCR STRUCTURE THERAPEUTICS INC 1.7%
Value $10.08M Shares 209,093 Share Price $48.20 Est. Cost/Share — Unrealized @ Report Date —
BHVN BIOHAVEN LTD 1.6%
Value $9.847M Shares 1,163,926 Share Price $8.46 Est. Cost/Share — Unrealized @ Report Date —
MNPR MONOPAR THERAPEUTICS INC 1.6%
Value $9.506M Shares 173,506 Share Price $54.79 Est. Cost/Share — Unrealized @ Report Date —
CRNX CRINETICS PHARMACEUTICALS IN 1.5%
Value $9.076M Shares 249,887 Share Price $36.32 Est. Cost/Share — Unrealized @ Report Date —
EWTX EDGEWISE THERAPEUTICS INC 1.4%
Value $8.473M Shares 268,986 Share Price $31.50 Est. Cost/Share — Unrealized @ Report Date —
CMPS COMPASS PATHWAYS PLC 1.4%
Value $8.331M Shares 1,506,525 Share Price $5.53 Est. Cost/Share — Unrealized @ Report Date —
QDEL QUIDELORTHO CORP 1.0%
Value $5.899M Shares 359,011 Share Price $16.43 Est. Cost/Share — Unrealized @ Report Date —
REPL REPLIMUNE GROUP INC 0.9%
Value $5.508M Shares 720,036 Share Price $7.65 Est. Cost/Share — Unrealized @ Report Date —
OGN ORGANON & CO 0.9%
Value $5.187M Shares 865,908 Share Price $5.99 Est. Cost/Share — Unrealized @ Report Date —
IRON DISC MEDICINE INC 0.7%
Value $4.169M Shares 65,203 Share Price $63.94 Est. Cost/Share — Unrealized @ Report Date —
IART INTEGRA LIFESCIENCES HLDGS C 0.6%
Value $3.609M Shares 383,140 Share Price $9.42 Est. Cost/Share — Unrealized @ Report Date —
CNC CENTENE CORP DEL 0.5%
Value $3.274M Shares 100,000 Share Price $32.74 Est. Cost/Share — Unrealized @ Report Date —
PRQR PROQR THERAPEUTICS N V 0.5%
Value $3.167M Shares 1,954,715 Share Price $1.62 Est. Cost/Share — Unrealized @ Report Date —
SI SHOULDER INNOVATIONS INC 0.5%
Value $3.061M Shares 210,641 Share Price $14.53 Est. Cost/Share — Unrealized @ Report Date —
KYMR KYMERA THERAPEUTICS INC 0.4%
Value $2.685M Shares 32,235 Share Price $83.29 Est. Cost/Share — Unrealized @ Report Date —
CNTX CONTEXT THERAPEUTICS INC 0.4%
Value $2.405M Shares 917,922 Share Price $2.62 Est. Cost/Share — Unrealized @ Report Date —
HYPR HYPERFINE INC 0.2%
Value $1.08M Shares 1,000,000 Share Price $1.08 Est. Cost/Share — Unrealized @ Report Date —
FHTX FOGHORN THERAPEUTICS INC 0.1%
Value $587K Shares 122,889 Share Price $4.78 Est. Cost/Share — Unrealized @ Report Date —
TERN TERNS PHARMACEUTICALS INC 0.1%
Value $532K Shares 10,100 Share Price $52.72 Est. Cost/Share — Unrealized @ Report Date —
ENTA ENANTA PHARMACEUTICALS INC 0.1%
Value $505K Shares 40,000 Share Price $12.63 Est. Cost/Share — Unrealized @ Report Date —
NMTC NEUROONE MED TECHNOLOGIES CO 0.1%
Value $386K Shares 496,614 Share Price $0.78 Est. Cost/Share — Unrealized @ Report Date —
BOLD BOUNDLESS BIO INC 0.0%
Value $180K Shares 163,679 Share Price $1.10 Est. Cost/Share — Unrealized @ Report Date —
NYXH NYXOAH S A 0.0%
Value $148K Shares 50,839 Share Price $2.92 Est. Cost/Share — Unrealized @ Report Date —
ELTX ELICIO THERAPEUTICS INC 0.0%
Value $125K Shares 11,700 Share Price $10.69 Est. Cost/Share — Unrealized @ Report Date —
ERAS ERASCA INC 0.0%
Value $80,900 Shares 5,000 Share Price $16.18 Est. Cost/Share — Unrealized @ Report Date —
OSCR OSCAR HEALTH INC 0.0%
Value $34,410 Shares 3,000 Share Price $11.47 Est. Cost/Share — Unrealized @ Report Date —
SLP SIMULATIONS PLUS INC 0.0%
Value $2,364 Shares 200 Share Price $11.82 Est. Cost/Share — Unrealized @ Report Date —

Decreased Positions (21)

DNTH DIANTHUS THERAPEUTICS INC 1.0%
Value $5.776M (-81.4%) Shares 59,254 (-84.0%) Share Price $97.48 Est. Cost/Share — Unrealized @ Report Date —
WAY WAYSTAR HLDG CORP 3.1%
Value $19.01M (-52.0%) Shares 925,834 (-43.6%) Share Price $20.53 Est. Cost/Share — Unrealized @ Report Date —
ICLR ICON PUB LTD CO 2.5%
Value $15.32M (-54.8%) Shares 88,186 (-71.2%) Share Price $173.71 Est. Cost/Share — Unrealized @ Report Date —
ANIP ANI PHARMACEUTICALS INC 1.3%
Value $8.055M (-60.6%) Shares 97,305 (-63.4%) Share Price $82.78 Est. Cost/Share — Unrealized @ Report Date —
MMS MAXIMUS INC 6.4%
Value $38.45M (-22.0%) Shares 715,267 (-7.0%) Share Price $53.76 Est. Cost/Share — Unrealized @ Report Date —
CELC CELCUITY INC 1.9%
Value $11.51M (-48.0%) Shares 110,022 (-43.2%) Share Price $104.62 Est. Cost/Share — Unrealized @ Report Date —
ABT ABBOTT LABORATORIES 1.9%
Value $11.67M (-39.1%) Shares 128,656 (-31.0%) Share Price $90.74 Est. Cost/Share — Unrealized @ Report Date —
SION SIONNA THERAPEUTICS INC 0.9%
Value $5.622M (-52.4%) Shares 127,808 (-56.6%) Share Price $43.99 Est. Cost/Share — Unrealized @ Report Date —
TARA PROTARA THERAPEUTICS INC 1.2%
Value $7.342M (-28.5%) Shares 1,921,872 (-2.4%) Share Price $3.82 Est. Cost/Share — Unrealized @ Report Date —
OCUL OCULAR THERAPEUTIX INC 0.9%
Value $5.298M (-35.4%) Shares 539,493 (-44.3%) Share Price $9.82 Est. Cost/Share — Unrealized @ Report Date —
VIR VIR BIOTECHNOLOGY INC 1.8%
Value $10.96M (-18.4%) Shares 1,075,274 (-28.2%) Share Price $10.19 Est. Cost/Share — Unrealized @ Report Date —
AQST AQUESTIVE THERAPEUTICS INC 1.0%
Value $6.182M (-22.5%) Shares 1,486,175 (-22.7%) Share Price $4.16 Est. Cost/Share — Unrealized @ Report Date —
RAPP RAPPORT THERAPEUTICS INC 2.1%
Value $12.82M (+11.7%) Shares 307,657 (-16.1%) Share Price $41.67 Est. Cost/Share — Unrealized @ Report Date —
ZBIO ZENAS BIOPHARMA INC 0.9%
Value $5.293M (-18.4%) Shares 208,557 (-37.1%) Share Price $25.38 Est. Cost/Share — Unrealized @ Report Date —
DRUG BRIGHT MINDS BIOSCIENCES INC 0.9%
Value $5.191M (-17.4%) Shares 73,952 (-14.1%) Share Price $70.20 Est. Cost/Share — Unrealized @ Report Date —
ADGM ADAGIO MED HLDGS INC 0.1%
Value $455K (-69.3%) Shares 698,989 (-45.8%) Share Price $0.65 Est. Cost/Share — Unrealized @ Report Date —
IMNM IMMUNOME INC 0.4%
Value $2.631M (-27.1%) Shares 124,168 (-24.8%) Share Price $21.19 Est. Cost/Share — Unrealized @ Report Date —
EYPT EYEPOINT INC 1.5%
Value $8.911M (-4.2%) Shares 623,130 (-13.7%) Share Price $14.30 Est. Cost/Share — Unrealized @ Report Date —
ANTX AN2 THERAPEUTICS INC 0.4%
Value $2.565M (+14.1%) Shares 529,933 (-19.4%) Share Price $4.84 Est. Cost/Share — Unrealized @ Report Date —
PMVP PMV PHARMACEUTICALS INC 0.6%
Value $3.53M (-7.5%) Shares 2,634,137 (-14.4%) Share Price $1.34 Est. Cost/Share — Unrealized @ Report Date —
OVID OVID THERAPEUTICS INC 0.4%
Value $2.704M (-2.7%) Shares 1,005,334 (-19.7%) Share Price $2.69 Est. Cost/Share — Unrealized @ Report Date —

Unchanged Positions (12)